Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0015 Transporter Info | ||||
| Gene Name | ABCC4 | ||||
| Transporter Name | Multidrug resistance-associated protein 4 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Cefoperazone Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 44187 | ||||
| Docking Score | -12.098 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C25H27N9O8S2 | ||||
| Molecular Weight | 645.7 | ||||
| Canonical SMILES |
CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O
|
||||
| InChI |
InChI=1S/C25H27N9O8S2/c1-3-32-8-9-33(21(39)20(32)38)24(42)27-15(12-4-6-14(35)7-5-12)18(36)26-16-19(37)34-17(23(40)41)13(10-43-22(16)34)11-44-25-28-29-30-31(25)2/h4-7,15-16,22,35H,3,8-11H2,1-2H3,(H,26,36)(H,27,42)(H,40,41)/t15-,16-,22-/m1/s1
|
||||
| InChIKey | GCFBRXLSHGKWDP-XCGNWRKASA-N | ||||
| Pharmaceutical Properties | Xlogp | -0.7 | Rotatable Bond Count | 9 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 13 | ||
| Xenobiotic Name | Folic acid Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 135398658 | ||||
| Docking Score | -11.322 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C19H19N7O6 | ||||
| Molecular Weight | 441.4 | ||||
| Canonical SMILES |
C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N
|
||||
| InChI |
InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1
|
||||
| InChIKey | OVBPIULPVIDEAO-LBPRGKRZSA-N | ||||
| Pharmaceutical Properties | Xlogp | -1.1 | Rotatable Bond Count | 9 | |
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 10 | ||
| Xenobiotic Name | Losartan Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 3961 | ||||
| Docking Score | -11.013 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C22H23ClN6O | ||||
| Molecular Weight | 422.9 | ||||
| Canonical SMILES |
CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
|
||||
| InChI |
InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)
|
||||
| InChIKey | PSIFNNKUMBGKDQ-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.3 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 5 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.